Form 483

Specialty Formulations & Manufacturing, LLC Form 483, 2025-09-12

FDA issued a Form 483 to Specialty Formulations & Manufacturing, LLC on 2025-09-12 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Specialty Formulations & Manufacturing, LLC · Phoenix, United States · Issued September 12, 2025

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Sep 2025
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Kevin T Nguyen

12 Sep 2025
21 CFR 211.22(a)

Lack of quality control unit

Cited by Kevin T Nguyen

12 Sep 2025
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Kevin T Nguyen

12 Sep 2025
21 CFR 211.84(a)

Components withheld from use pending release

Cited by Kevin T Nguyen

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere